华夏医学2024,Vol.37Issue(6) :18-24.DOI:10.19296/j.cnki.1008-2409.2024-06-003

APOE基因多态性与糖脂代谢病的相关研究进展

Research progress on the correlation between APOE gene polymorphism and glycolipid metabolic disorders

刘学 欧明林
华夏医学2024,Vol.37Issue(6) :18-24.DOI:10.19296/j.cnki.1008-2409.2024-06-003

APOE基因多态性与糖脂代谢病的相关研究进展

Research progress on the correlation between APOE gene polymorphism and glycolipid metabolic disorders

刘学 1欧明林1
扫码查看

作者信息

  • 1. 桂林医学院第二附属医院中心实验室,桂林 541199;广西慢性病代谢重塑与智能医学工程重点实验室,桂林 541199
  • 折叠

摘要

糖脂代谢病(GLMD)是一种复杂的代谢紊乱疾病,主要表现为糖类和脂质的代谢异常,同时常伴随着多种靶器官的损伤.随着全球GLMD发病率的逐年上升,能够对其实行早期、有效干预的需求也日益凸显.载脂蛋白E(APOE)在脂质代谢中起着关键作用,与GLMD的发生和发展密切相关.本文旨在通过深入探讨GLMD的发病机制,特别是关注APOE 的基因多态性在其中的遗传学基础,详细阐述APOE 基因多态性与GLMD之间的内在联系及机制,并进一步探讨如何利用这一关系来预测和诊断GLMD,期望能够为GLMD的预防、诊断和治疗提供更为全面和深入的理解.

Abstract

Glycolipid metabolic disorders(GLMD)is a complex metabolic disorder characterized by abnormal metabolism of sugars and lipids,often accompanied by damage to multiple target organs.With the global GLMD incidence rate rising year by year,the need for early and effective intervention is also increasingly prominent.Apolipoprotein E(APOE)plays a crucial role in lipid metabolism and is closely related to the occurrence and development of GLMD.This article aims to explore the pathogenesis of GLMD in depth,with a particular focus on the genetic basis of APOE gene polymorphism.It elaborates on the intrinsic relationship and mechanism between APOE gene polymorphism and GLMD,and further explores how to use this relationship to predict and diagnose GLMD.The goal is to provide a more comprehensive and in-depth understanding for the prevention,diagnosis,and treatment of GLMD.

关键词

糖脂代谢病/载脂蛋白E/基因多态性

Key words

glycolipid metabolic disorders/apolipoprotein E/gene polymorphism

引用本文复制引用

出版年

2024
华夏医学
桂林医学院

华夏医学

影响因子:0.569
ISSN:1008-2409
段落导航相关论文